Dishman Carbogen Amcis Q4 Results
- BSE: 540701
- NSE: DCAL
- ISIN: INE385W01011
- Sector: Biotechnology & Drugs
BSE
177.35
2.45 (1.40%)
2.45 (1.40%)Volume14.21 K
Updated: Wed 13 May, 2026 | 15:29:00
NSE
176.101.27 (0.73%)
1.27 (0.73%)Volume1.44 L
Updated: Wed 13 May, 2026 | 15:53:55
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 25
Note: Comparison is on QoQ basis
Quarterly - Dishman Carbogen Amcis Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 654.49 | 691.11 | 6.92% | 664.24 | -1.47% |
| Depreciation/ Amortization | 79.09 | 84.42 | 9.89% | 85.00 | -6.95% |
| Operating Income | 61.85 | 28.69 | -11.89% | -9.53 | 0.00% |
| Net Income | 43.09 | -12.97 | 830.67% | -69.92 | 0.00% |
| Other Operating Expenses Total | 92.07 | 109.33 | -16.88% | 63.71 | 44.51% |
| Net Income Before Taxes | 27.70 | -10.44 | 2.40% | -49.20 | 0.00% |
| Total Revenue | 716.34 | 719.80 | 4.98% | 654.71 | 9.41% |
| Selling/ General/ Admin Expenses Total | 324.94 | 355.88 | -2.15% | 330.30 | -1.62% |
| Diluted Normalized EPS | 3.24 | -0.83 | 1414.45% | -4.07 | 0.00% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.